VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations
出版年份 2014 全文链接
标题
VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations
作者
关键词
-
出版物
mAbs
Volume 6, Issue 6, Pages 1638-1648
出版商
Informa UK Limited
发表日期
2014-08-14
DOI
10.4161/mabs.34454
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
- (2013) Miroslav Dostalek et al. CLINICAL PHARMACOKINETICS
- Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer
- (2013) Laure Belmont et al. INTERNATIONAL JOURNAL OF CANCER
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis
- (2012) T. Jiang et al. BLOOD
- Exploiting pleiotropic activities of semaphorins as multi-target therapies for cancer
- (2012) Lidia Moserle et al. EMBO Molecular Medicine
- Anti-angiogenic drug discovery: lessons from the past and thoughts for the future
- (2012) Jessie M Wu et al. Expert Opinion on Drug Discovery
- Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
- (2012) Nathan T. Ihle et al. JNCI-Journal of the National Cancer Institute
- Impact of Systematic EGFR and KRAS Mutation Evaluation on Progression-Free Survival and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Treated by Erlotinib in a French Prospective Cohort (ERMETIC Project—Part 2)
- (2012) Jacques Cadranel et al. Journal of Thoracic Oncology
- Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy
- (2011) Satoru Takahashi BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads
- (2011) Annamaria Rapisarda et al. CELL CYCLE
- Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells
- (2011) L. von Baumgarten et al. CLINICAL CANCER RESEARCH
- Antiangiogenic therapy, hypoxia and metastasis: risky liaisons, or not?
- (2011) Katrien De Bock et al. Nature Reviews Clinical Oncology
- The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors
- (2011) Agnès Maillet et al. PHARMACEUTICAL RESEARCH
- A Differential Concentration-Dependent Effect of IVIg on Neutrophil Functions: Relevance for Anti-Microbial and Anti-Inflammatory Mechanisms
- (2011) Sarah Casulli et al. PLoS One
- Suppression of hypoxia-induced HIF-1α accumulation by VEGFR inhibitors: Different profiles of AAL993 versus SU5416 and KRN633
- (2010) Hyun Seung Ban et al. CANCER LETTERS
- HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer
- (2010) Autumn L Jackson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: Relation to prognosis
- (2009) Barbara Bonnesen et al. LUNG CANCER
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blocking Vascular Endothelial Growth Factor-A Inhibits the Growth of Pituitary Adenomas and Lowers Serum Prolactin Level in a Mouse Model of Multiple Endocrine Neoplasia Type 1
- (2008) N. Korsisaari et al. CLINICAL CANCER RESEARCH
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now